company

DOCCONTROL AS

1341 SLEPENDEN

Return on Equity
10,4 %
Current Ratio
12,36
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue891 000
Net Income104 000
Total Assets1 088 000
Total Equity1 000 000
Income (NOK)2022
Revenue891 000
Expenditure758 000
Operating Profit133 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax133 000
Tax28 000
Net Income104 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets1 088 000
Total Assets1 088 000
Total Retained Equity970 000
Total Equity1 000 000
Total Long-Term Debt0
Total Current Debt88 000
Total Equity and Debt1 088 000
Cash flow (NOK)2022
Sales Income891 000
Other Income0
Revenue891 000
Cost of Goods Sold0
Salary Costs721 000
Depreciation−4 000
Impairment0
Expenditure758 000
Operating Profit133 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income104 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments840 000
Cash, Bank247 000
Total Current Assets1 088 000
Total Assets1 088 000
Total Equity1 000 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes7 000
Dividends0
Other Current Debt52 000
Total Current Debt88 000
Total Equity and Debt1 088 000
Financial indicators2022
Return on Equity10,4 %
Debt-to-Equity Ratio0
Operating Profit Margin14,93 %
Current Ratio12,36
Quick Ratio12,36
Equity Ratio0,92
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English